Mariner
INMB icon

Mariner’s INmune Bio INMB Stock Holding History

Mariner’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Buy
40,320
+21,277
+112% +$29.4K ﹤0.01% 3391
2026
Q1 		$21.5K Buy
19,043
+8,793
+86% +$12.5K ﹤0.01% 3488
2025
Q4 		$16K Sell
10,250
-2,081
-17% -$3.71K ﹤0.01% 3494
2025
Q3 		$25.5K Buy
12,331
+1,452
+13% +$3.32K ﹤0.01% 3500
2025
Q2 		$25.1K Buy
+10,879
New +$79.8K ﹤0.01% 3402
2025
Q1 		– Sell
-13,836
Closed -$64.6K – 3522
2024
Q4 		$64.6K Buy
+13,836
New +$72.1K ﹤0.01% 3258

Other funds holding INMB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mariner's INMB Position: Q2 2026 in Review

Mariner increased its INmune Bio (INMB) stake by 112% in Q2 2026, buying an estimated $29.4K and bringing the position to 40,320 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3391.

Mariner first reported a position in INMB in Q4 2024 and has held it in 6 quarters since. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.

  • Mariner held 40,320 shares of INmune Bio worth $65.7K as of Q2 2026.
  • Mariner bought 21,277 INmune Bio shares in Q2 2026, an estimated $29.4K.
  • INmune Bio made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3391 holding.
  • Mariner first reported a position in INmune Bio in Q4 2024 and has held it in 6 quarters since.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.